•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Levi & Korsinsky has notified investors that it has commenced an investigation into Option Care Health, Inc. (NASDAQ: OPCH) regarding potential violations of the federal securities laws.
Option Care Health’s Q1 2026 earnings report showed a revenue shortfall versus analyst expectations. At the same time, the company reduced its FY 2026 revenue guidance by up to 3.75%, representing a cut of as much as $225 million from the top end of its prior range.
The revised FY 2026 outlook is $5.675 billion to $5.775 billion, compared with the prior $5.8 billion to $6.0 billion range that CEO John Rademacher and CFO Meenal Sethna had reaffirmed 65 days earlier on the Q4 2025 earnings call on February 24, 2026.
The company attributed part of the guidance reduction to increased headwinds from the Stelara biosimilar conversion. On February 24, 2026, CFO Sethna quantified the FY 2026 headwind at $25 million to $35 million. By April 30, the headwind had increased to $55 million, as the number of Stelara patients converting to some other therapy was below expectations, leading to lower census and revenue expectations.
The projected “400 basis point revenue growth headwind” also rose quickly to “600 basis points” of CID portfolio headwinds.
Levi & Korsinsky said the investigation concerns potential violations of the federal securities laws related to the company’s disclosures and performance, including the revenue shortfall and guidance changes described in the Q1 2026 reporting period.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
